Cefixime as an Oral Alternative to Ceftriaxone

Primary Oral Alternative

The Centers for Disease Control and Prevention recommends cefixime as the standard oral cephalosporin substitute for ceftriaxone for conditions like gonorrhea when oral therapy is appropriate 1
Cefixime has an antimicrobial spectrum similar to ceftriaxone but does not provide as high or sustained bactericidal levels as ceftriaxone 125 mg IM 2, 3, 1
In clinical trials, cefixime 400 mg cured 97.1-97.4% of uncomplicated urogenital and anorectal gonococcal infections, compared to 98.9-99.1% for ceftriaxone 2, 3

Cefixime monotherapy shows higher failure rates (5.8%) compared to ceftriaxone-based regimens (1.8%) for pharyngeal gonorrhea, which is a critical consideration when selecting therapy 1
Cefixime provides lower and less sustained bactericidal levels than ceftriaxone 125 mg IM, making it less effective for serious infections requiring high tissue penetration 1
Ceftriaxone cannot be given orally as it is not absorbed adequately from the gastrointestinal tract; it must be administered by IV or IM injection 1

Other oral cephalosporins like cefuroxime axetil are second-generation agents with more limited Gram-negative coverage and no activity against drug-resistant S. pneumoniae, making them less comparable to ceftriaxone 4

The American College of Physicians and other guideline societies imply that prescribers should never confuse ceftriaxone with oral cephalosporins—ceftriaxone has no oral formulation and prescribers should specifically order cefixime or another appropriate oral cephalosporin when oral therapy is intended 1